It’s upsetting to learn you have a chronic disease that you can’t control. Especially when you’re told by doctors that it’s very hard to reverse. Well, you might be surprised to learn that it’s not as hard as you think. And you might be pleasantly surprised by how much you can accomplish once you’re motivated …
Children with type 1 diabetes miss nine more school days annually on average than children without the condition, according to a recent Cardiff University study.
Researchers recently created an artificial intelligence model that predicts diabetes onset with 12 hours of blood glucose data collected from a wearable device. The AI model could help diagnose prediabetes and prevent type 2 diabetes.
Salisott has lived with Type 1 for over three decades.
As part of the NFL’s ‘My Cause, My Cleats’ campaign, Rader plans to wear cleats that bring attention to JDRF (Juvenile Diabetes Research Foundation). The words “Improving Lives Curing Type 1 Diabetes” will be inscribed on the colorful shoes.
Former Disney star Jennifer Stone opens up to Diagnosis Diaries about her challenging diagnosis experience and how it’s inspired her to help others.
Lexicon Pharmaceuticals won’t take no for an answer. | Lexicon is continuing its three-year battle with the FDA to gain approval for Type 1 diabetes prospect sotagliflozin, asking that the regulator reconsider its rejection of a request for an expert hearing.
UCF alum and Harvard-MIT bioengineering doctoral student Christopher Clifford ’22 shares his personal and professional insights into diabetes, finding your own version of success, and his hopes for the future of bioengineering.
A bacterial protein stimulates the reproduction of insulin-producing cells, pointing to a potential treatment. Nearly ten years ago, graduate student Jennifer Hampton Hill of the University of Oregon (UO) made a fortuitous find: a protein produced by gut bacteria that triggered the division of cell
Three health organisations have appointed 17 leading international scientists to advise on its £50 million investment into type 1 diabetes research. The Steve Morgan Foundation, Diabetes UK and JDRF UK are recruiting for its Type 1 Diabetes Grand Challenge – a project that is funding research to drive breakthroughs in type 1 diabetes treatments and …